Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fraction patients: The Beta GenTURK study
Objective: The present objective was to determine frequency of Arginine389Glycine (Arg389Gly) and Cytochrome p450 2D6*10 (Cyp2D6*10) polymorphism in cases of heart failure-reduced ejection fraction (HFREF), and to evaluate the influence of the polymorphisms in response to beta-blocker (BB) therapy....
Saved in:
Main Authors: | Mehdi Zoghi (Author), Hakki Kaya (Author), Yuksel Cavusoglu (Author), Enbiya Aksakal (Author), Serafettin Demir (Author), Ceyhun Yucel (Author), Hasim Mutlu (Author), Oktay Ergene (Author), Mehmet Birhan Yilmaz (Author), On Behalf Of The Beta Genturk Study (Author) |
---|---|
Format: | Book |
Published: |
KARE Publishing,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta-Adrenergic Agonists
by: Giovanni Barisione, et al.
Published: (2010) -
Beta-Adrenergic Blockade in Critical Illness
by: Rebecca Bruning, et al.
Published: (2021) -
Genetic Polymorphism of beta1-adrenergic Receptors and the Effect on the Clinical Efficacy of beta-adrenoblockers
by: V. N. Larina, et al.
Published: (2021) -
β-Hydroxybutyrate Mitigated Heart Failure with Preserved Ejection Fraction by Increasing Treg Cells via Nox2/GSK-3β
by: Liao S, et al.
Published: (2021) -
Macrophage beta2-adrenergic receptor is dispensable for the adipose tissue inflammation and function
by: Kasparas Petkevicius, et al.
Published: (2021)